drugset / Trial / NCT02304523

Safety and Efficacy of CDFR0612 and CDFR0613 for Bowel Cleansing Before Colonoscopy

NCT02304523

Phase 3 Completed 310 enrolled CTC Bio, Inc. Symyoo · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of CDFR0612 and CDFR0613 compared to PEG+picosulfate (Coolprep Powder) preparation. The effectiveness for bowel cleansing will be assessed with Harefield Cleansing Scale (HCS) by blinded assessor.

Timeline

Start
2015-01
Primary completion
2015-08
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject CDFR0612 Unknown 150 ml Oral
Subject CDFR0613 Unknown 150 ml Oral
Comparator Moviprep Other / unclassified 500 ml Oral

Indications